Latest Articles

Multiple Myeloma Bendamustine-triplet in Front-line Multiple Myeloma

Bendamustine-triplet in Front-line Multiple Myeloma

The combination of bendamustine, bortezomib, and dexamethasone was reported to be effective in achieving overall response rates in myeloma.

Lymphoma Is There a Link Between Familial Autoimmunity and Lymphoma?

Is There a Link Between Familial Autoimmunity and Lymphoma?

Research is needed to identify the potentially overlapping molecular pathways involved in autoimmunity and B-cell neoplasms.

Breast Cancer Q&A With Chris Bakal, PhD: Big Data and Cancer Cell-shape Research

Q&A With Chris Bakal, PhD: Big Data and Cancer Cell-shape Research

Cancer Therapy Advisor interviewed Dr Bakal about this new approach to analyzing cell shape and its potential to affect breast cancer treatment.

Genitourinary Cancers Symposium 2017 Explaining Androgen Receptor-indifferent Prostate Cancer

Explaining Androgen Receptor-indifferent Prostate Cancer

Physicians will speak about tumor evolution and AR-indifferent disease at the 2017 ASCO Genitourinary Cancers Symposium in Orlando, Florida.

Genitourinary Cancers Symposium 2017 2017 ASCO GU Symposium: Updates in Managing Small Renal Masses

2017 ASCO GU Symposium: Updates in Managing Small Renal Masses

At a general session at the 2017 ASCO GU Symposium, the latest advances in managing SRMs will be discussed.

Genitourinary Cancers Symposium 2017 Clinicians Address Barriers to Progress for Bladder Cancer

Clinicians Address Barriers to Progress for Bladder Cancer

At an education session at the 2017 GU Symposium experts will discuss some of the barriers to progress in the treatment of bladder cancer.

Chronic Myeloid Leukemia Navigating the Costs of Chronic Myeloid Leukemia: A Glimpse Into the Future

Navigating the Costs of Chronic Myeloid Leukemia: A Glimpse Into the Future

The cost of treating CML can be crippling, and it's unclear whether future approvals or policies will improve the financial toxicity associated with the disease.

Breast Cancer Weight Gain: A Risk Factor for Postmenopausal Breast Cancer

Weight Gain: A Risk Factor for Postmenopausal Breast Cancer

While women who lost more than 5 kg after age 18 were at a 23% reduced risk for breast cancer, those who gained more than 30 kg were at a 32% increased risk.

General Oncology ASCO Advance of the Year: Immunotherapy 2.0

ASCO Advance of the Year: Immunotherapy 2.0

The American Society of Clinical Oncology (ASCO) named Immunotherapy 2.0 the "advance of the year."

Multiple Myeloma Multiple Myeloma: Survival Hinges on Treatment Facility Volume

Multiple Myeloma: Survival Hinges on Treatment Facility Volume

Patients who are treated for multiple myeloma at high-volume cancer centers have better survival outcomes than those receiving care at low-volume facilities.

Prostate Cancer Prostate Cancer: In Search of Predictive Biomarkers for Immunotherapy

Prostate Cancer: In Search of Predictive Biomarkers for Immunotherapy

Scientists are testing immune checkpoint proteins, CD8 T cell clonal expansion, mutational load, and PSA levels as predictive biomarkers for prostate cancer immunotherapy outcomes.

Lung Cancer Smoking Cessation After Diagnosis: A Consistent Survival Benefit

Smoking Cessation After Diagnosis: A Consistent Survival Benefit

Smoking cessation may improve survival regardless of the type of cancer diagnosed, due to a reduction in comorbidities.

Breast Cancer Triple-negative Breast Cancer: New Strategies for Targeted Therapy

Triple-negative Breast Cancer: New Strategies for Targeted Therapy

Despite the success of targeted therapy in other cancers, targeted therapy has failed to improve outcomes in triple-negative breast cancer.

Multiple Myeloma Selinexor for Relapsed/Refractory Multiple Myeloma

Selinexor for Relapsed/Refractory Multiple Myeloma

Selinexor represents a much-needed therapeutic addition to the available agents for the treatment of heavily pre-treated patients with few options.

Skin Cancer Melanoma: A Need for Specialty Clinics

Melanoma: A Need for Specialty Clinics

Specialized treatment centers would bring together oncology faculty capable of managing the administration of drugs, including immunotherapies.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters